Parsippany-based Watson Pharmaceuticals Inc. agreed Tuesday to acquire drugmaker Actavis Group, of Zug, Switzerland, for $5.6 billion, creating the third-largest global generics company in the world with $8 billion in anticipated 2012 revenue.
Read More »